Cephalosporins are one of the largest and most diverse family of antibiotics of the bactericidal β-lactam group. Based on their antimicrobial activity, they are grouped into various type of generations. Cephalosporin inhibits enzymes in the cell wall of susceptible bacteria, hence disrupting cell synthesis. Increasing research and development activities, and increasing demand for antibacterial drugs is propelling the growth of cephalosporin market.
The market for cephalosporin would continue to rise immensely with the aging population and increasing incidences of infectious diseases worldwide. Cephalosporin have a broad range of therapeutic application and are effective in the treatment of streptococcal, pneumococcal, staphylococcal, Klebsiella, Escherichia coli and Proteus infections. One of the significant roles of cephalosporin has been as chemoprophylactic agents at the time of surgical procedures. In addition, cephalosporin has the ability to retain excellent pharmacokinetic properties, hence making cephalosporin drugs as the first choice for treatment of various infections. However, factors such as certain side-effects associated with cephalosporin and development of drug-resistant bacterial strains might restrain the growth of cephalosporin market.
Market Classification and Overview
The cephalosporin market is segmented on the basis of generation, route of administration, type, application and geography. Based on route of administration, the market is segmented into oral and injection. The injection route of administration is anticipated to grow swiftly during the forecast period owing to its ease-of-use, and better patient compliance.
Based on application, the global market has been bifurcated into sexually transmitted infection, respiratory tract infection, skin infection, ear infection, and urinary tract infection. Sexually transmitted infection dominated the application segment in 2016. Factors such as increasing number of people suffering from sexually transmitted diseases, and excellent efficacy of cephalosporin as antibiotics are driving the market growth. According to the WHO, more than 1 million sexually transmitted infections are acquired each day worldwide.
Regionally, the market for cephalosporin is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America is dominating the global market owing to the presence of highly advanced healthcare facilities, and presence of large number of patient population affected with sexually transmitted diseases. However, Asia-Pacific is expected to grow at the fastest CAGR due to increased population base, growing disposable income in countries like China and India, and beneficial government initiatives.
2015 – 2026
2015 – 2016
2018 – 2026
Generation, Route of Administration, Type, Application, Geography
North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,
Player Profiling, Value Chain Analysis
F. Hoffmann-La Roche Ltd., Lupin Limited, Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. are the key players in the cephalosporin market. These players have undertaken mergers and acquisitions as one of their key strategies in order to maximize their share in the global market.
Market By Generation
· First Generation
· Second Generation
· Third Generation
· Fourth Generation
· Fifth Generation
Market By Route of Administration
Market By Type
Market By Application
· Sexually Transmitted Infection
· Respiratory Tract Infection
· Skin Infection
· Ear Infection
· Urinary Tract Infection
Market By Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,
The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu
The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro
The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased
The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo
The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t